Off-Label Use of Oncology Drugs: The Need for More Data and Then Some
Author:
Affiliation:
1. Memorial Sloan-Kettering Cancer Center, New York, NY
Publisher
American Society of Clinical Oncology (ASCO)
Subject
Cancer Research,Oncology
Reference24 articles.
1. The off-label use of drugs in oncology: a position paper by the European Society for Medical Oncology (ESMO)
2. "Off-Label" Indications for Oncology Drug Use and Drug Compendia: History and Current Status
3. Reimbursement for Cancer Treatment: Coverage of Off-Label Drug Indications
4. Off-label prescribing in oncology
Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Evolving and Improving the Sustainability of Molecular Tumor Boards: The Value and Challenges;Cancers;2024-08-20
2. Advancing perspectives on the off-label use of anticancer drugs: an updated classification and exploration of categories;Frontiers in Pharmacology;2024-06-04
3. The effect of RCTs on drug demand: Evidence from off-label cancer drugs;Journal of Health Economics;2023-07
4. Influence of data disclosures on physician decisions about off-label uses: findings from a qualitative study;BMC Primary Care;2022-04-19
5. Artificial intelligence unifies knowledge and actions in drug repositioning;Emerging Topics in Life Sciences;2021-12-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3